An EORTC phase II study of mitoxantrone in solid tumors and lymphomas
- 30 November 1984
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 20 (11), 1369-1375
- https://doi.org/10.1016/0277-5379(84)90055-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Mitoxantrone (novantrone): a review of experimental and early clinical studiesCancer Treatment Reviews, 1983
- Interactions of a new antitumor agent, 1,4-dihydroxy-5,8-bis[[2-[(2-hydroxyethyl)amino]-ethyl]amino]-9,10-anthracenedione, with nucleic acidsBiochemical Pharmacology, 1981
- Phase I clinical trial of mitoxantrone: A new anthracenedione anticancer drugCancer Chemotherapy and Pharmacology, 1980
- Comparison of Antineoplastic Activity of Aminoethylaminoanthraquinones and Anthracycline AntibioticsJournal of Pharmaceutical Sciences, 1979
- Antineoplastic agents. Structure-activity relationship study of bis(substituted aminoalkylamino)anthraquinonesJournal of Medicinal Chemistry, 1978
- Integration of chemotherapy into combined modality treatment of solid tumors: VII. Adenocarcinoma of the breastCancer Treatment Reviews, 1976
- Evaluation of the binding of some substituted anthraquinones and naphthacenequinones to DNAJournal of Pharmacy and Pharmacology, 1976
- The interaction of aminoalkylaminoanthraquinones with deoxyribonucleic acidJournal of Pharmacy and Pharmacology, 1975
- The determination of the number of patients required in a preliminary and a follow-up trial of a new chemotherapeutic agentJournal of Chronic Diseases, 1961